首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4240篇
  免费   454篇
  2022年   33篇
  2021年   87篇
  2020年   46篇
  2019年   52篇
  2018年   60篇
  2017年   52篇
  2016年   100篇
  2015年   160篇
  2014年   182篇
  2013年   180篇
  2012年   267篇
  2011年   222篇
  2010年   131篇
  2009年   130篇
  2008年   178篇
  2007年   185篇
  2006年   143篇
  2005年   136篇
  2004年   148篇
  2003年   152篇
  2002年   141篇
  2001年   100篇
  2000年   100篇
  1999年   81篇
  1998年   47篇
  1997年   34篇
  1996年   31篇
  1995年   41篇
  1994年   35篇
  1993年   53篇
  1992年   83篇
  1991年   74篇
  1990年   68篇
  1989年   69篇
  1988年   67篇
  1987年   62篇
  1986年   40篇
  1985年   50篇
  1984年   64篇
  1983年   49篇
  1982年   35篇
  1980年   44篇
  1979年   43篇
  1978年   47篇
  1977年   40篇
  1976年   50篇
  1975年   44篇
  1974年   39篇
  1973年   46篇
  1972年   31篇
排序方式: 共有4694条查询结果,搜索用时 15 毫秒
1.
Parkinson's disease (PD) patients show a characteristic loss of motor control caused by the degeneration of dopaminergic neurons. Mutations in the genes that encode alpha-synuclein and parkin have been linked to inherited forms of this disease. The parkin protein functions as a ubiquitin ligase that targets proteins for degradation. Expression of isoforms of human alpha-synuclein in the Drosophila melanogaster nervous system forms the basis of an excellent genetic model that recapitulates phenotypic and behavioural features of PD. Using this model, we analysed the effect of parkin co-expression on the climbing ability of aging flies, their life span, and their retinal degeneration. We have determined that co-expression of parkin can suppress phenotypes caused by expression of mutant alpha-synuclein. In the developing eye, parkin reduces retinal degeneration. When co-expressed in the dopaminergic neurons, the ability to climb is extended over time. If conserved in humans, we suggest that upregulation of parkin may prove a method of suppression for PD induced by mutant forms of alpha-synuclein.  相似文献   
2.
Summary A family is described in which four affected males, spanning two generations, have hyperuricemia and gout accompanied by hematuria but are without severe neurologic involvement. The affected males were found to have markedly reduced levels of erythrocytic hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity; these were 5–12% with hypoxanthine and 0.5–3% with guanine as compared to controls. Erythrocytic adenine phosphoribosyltransferase (APRT) was approximately three-fold elevated in the affected individuals.The residual HGPRT activity in affected males enabled characterization of some of the properties of this mutation. The apparent Michaelis constants (km) for both hypoxanthine and guanine were essentially unchanged, whereas the km for PP-ribose-P was approximately 10–20-fold elevated for all four affected males. The enzyme was more sensitive to product inhibition by IMP and GMP than controls, and exhibited greater thermal lability at 65°C than found with control lysates.  相似文献   
3.
4.
5.
Ellis, M. B. , Dematiaceous Hyphomycetes. Microbes and Biological Productivity , D. E. HUGHES and A. H. ROSE (Eds.)  相似文献   
6.
7.
Absorption and fluorescence changes were used to monitor the thermally induced folding-unfolding transition of beta-trypsin. These parameters reflect changes in the microenvironment of different subsets of the four tryptophanyl residues of this protein. The thermal transition was found to be sequential.  相似文献   
8.
Small-Sized Mutants of SACCHAROMYCES CEREVISIAE   总被引:5,自引:0,他引:5       下载免费PDF全文
The isolation of mutants of Saccharomyces cerevisiae that divide at approximately half the size of the wild type is described. Three mutants have been isolated in which the small size at bud initiation is due to a mutation in a single nuclear gene.  相似文献   
9.
10.
[Acyl CoA]monoacylglycerol acyltransferase 2 (MGAT2) is of interest as a target for therapeutic treatment of diabetes, obesity and other diseases which together constitute the metabolic syndrome. In this Letter we report our discovery and optimisation of a novel series of MGAT2 inhibitors. The development of the SAR of the series and a detailed discussion around some key parameters monitored and addressed during the lead generation phase will be given. The in vivo results from an oral lipid tolerance test (OLTT) using the MGAT2 inhibitor (S)-10, shows a significant reduction (68% inhibition relative to na?ve, p <0.01) in plasma triacylglycerol (TAG) concentration.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号